Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:20:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new phase II trial of Pembrolizumab (MK-3475) in combination with Bacillus Calmette-Guérin (BCG) for high-risk T1 bladder cancer and high-grade NMI-UTUC, with significant changes in the trial's description and inclusion criteria.
    Difference
    43%
    Check dated 2025-04-16T10:48:18.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 17, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T05:17:49.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:33:37.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The webpage has updated its contact information, replacing Dean Bajorin, MD with Gopakumar Iyer, MD, and has adjusted the relevant dates for updates and availability.
    Difference
    3%
    Check dated 2025-03-18T07:09:02.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:48:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.